Despite being one of the first countries globally to introduce multidrug-resistant tuberculosis (MDR-TB) case management, the number of MDR-TB cases is continuing to rise in Nepal. Rapid molecular tests applicable in this setting to identify resistant organisms would be an effective tool in reversing this trend. To develop such tools, information about the frequency and distribution of mutations that are associated with phenotypic drug resistance in Mycobacterium tuberculosis is required. In the present study, we investigated the prevalence of mutations in rpoB and katG genes and the inhA 
INTRODUCTION
With an estimated 9 million new cases and 2 million deaths every year, tuberculosis (TB) represents one of the most serious infectious diseases worldwide (35) .
The increasing spread of multidrug-resistant TB (MDR-TB), resistant to at least two drugs including isoniazid (INH) and rifampicin (RIF), and the recent emergence of 3 extensively drug-resistant TB (XDR-TB), with additional resistance to a fluoroquinolone (FQ) and at least one of the three injectable second-line drugs, possess a significant threat to tuberculosis control (19, 35) . Lack of adequate treatment, often due to irregular drug supply, inappropriate regimens or poor patient compliance is associated with the emergence of drug-resistant M. tuberculosis (9, 13) . In 2008, approximately 440,000 cases of MDR-TB were estimated throughout the world, and 58 nations had reported to WHO at least one case of XDR-TB (19, 21, 35) . Among the countries listed in the WHO report, India and China had the highest burden of MDR-TB, together accounting for almost half of the world's total cases (19, 35) . In Nepal, the incidence of all forms of TB was estimated to be 173/100,000 population while the incidence of new smear-positive cases was at 77/100,000 in 2008 (14, 35) . According to the national drug resistance survey conducted in 2006, the prevalence of MDR-TB in Nepal among new and retreatment cases were 2.9 and 11.7%, respectively (14) .
Nepal is a landlocked country in South East Asia, bounded to the north by China and to the south by India, sharing an open border with India. Every year, a large number of people of Nepal and India cross the border for various purposes, such as work, study, trade, pilgrimage, cultural visits, and so on. According to the 2001 census of Nepal, 762,181 people were abroad, with 78% in India. The census recorded 116,571 foreign citizens residing in Nepal, of whom 88% were Indians (20). However, this information doesn't adequately cover the short-term and short-distance mobility that could significantly contribute TB epidemics in Nepal. Since drug resistance rates on one side of the border impact the other side of the border (33), a high proportion of MDR-TB in Nepal may reflect the possible dissemination of infection from surrounding two countries, mainly from India.
Rapid determination of the antimicrobial susceptibility pattern in clinical isolates of M. tuberculosis is important for the early administration of appropriate therapeutic agents for the prevention of additional resistance development (21) . In this context, molecular characterization of drug resistance by identifying mutations in associated 4 genes will be applicable for developing a potential rapid molecular drug susceptibility test as an alternative to conventional methods (16, 23) .
The collection of data from different countries has indicated that resistance to RIF in more than 90% of cases is due to mutations resulting in an amino acid substitution within the 81-bp core region of the RNA polymerase β-subunit gene (rpoB), called the RIF resistance-determining region (RRDR) (8, 24, 26, 30) . In contrast, INH resistance is mediated by mutations in several genes, most frequently within the katG gene, encoding a catalase-peroxidase which transforms INH into its active form (6, 11, 24) and in the promoter region of inhA, encoding a putative enzyme involved in mycolic acid biosynthesis. An up-regulation mutation in the inhA promoter region results in the overexpression of InhA and develops INH resistance via a titration mechanism (24) .
The present study aimed to determine the prevalence of resistance-associated mutations in three specific genes (rpoB, katG and the inhA promoter region) of M. DNA extraction. DNAs were prepared for PCR by mechanical disruption, as described previously (29) . Briefly, the colonies were suspended in TE buffer consisting of 10mM
Tris-HCl (pH 8.0) and 1 mM EDTA in a 2 ml screw-cap vial, one-fourth of which was filled with 0.5 g glass beads (0.1 mm) (Bio Spec Products Inc., OK, USA).
Mycobacterial cells were disrupted by shaking with 0.5 ml chloroform on a cell disrupter (Micro smash; Tomy Seiko Co. Ltd., Tokyo, Japan) for 1 min. After centrifugation, the DNAs in the upper layer were concentrated by ethanol precipitation and dissolved in 100 µl TE buffer.
Species differentiation multiplex PCR. MTC species were identified on the isolates by a multiplex PCR with primer pairs designed to amplify three genetic regions (cfp32, RD9 and RD12), as described previously (18) . (Table 3) . A single nucleotide alteration in codon 531, resulting in the amino acid substitution of Ser to Leu, was most prevalent and observed in 62 isolates (56.9%). The second most affected codons were 516 and 526, which were found in 17 (15.6%) isolates each, and had 3 and 6 types of amino acid substitutions, respectively. Five (4.6%) isolates had a mutation in codon 513 and 3 (2.8%) had a mutation in codon 533. An Insertion of Phe between codons 514 and 515 was observed in 2 (1.8%) isolates, one of which had an additional point mutation affecting codon 531. Two isolates carried double mutations in two separate codons: 513 and 526; and 516 and 533, respectively. No mutations were detected in the remaining 3 (2.8%) RIF-resistant and 49 RIF-susceptible isolates.
Sequencing of rpoB
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Mutations in katG encoding region and inhA promoter region. Out of 113 phenotypically INH-resistant isolates, 99 (87.6%) had katG mutations, the vast majority of which was a commonly described substitution KatG Ser315Thr ( RIF resistance is often considered as a surrogate marker for checking MDR-TB (7, 24) . This hypothesis is supported by the finding in this study that 100% of the RIFresistant isolates were MDR. Consistent with previous studies that around 95% of RIFresistant M. tuberculosis isolates worldwide have mutations within the 81-bp core 8 region of the rpoB gene, we found mutations in this region in 97.3% of RIF-resistant isolates. The most frequently mutated codon in our study was codon 531 (58.7%), which was similar to those reported in clinical isolates from India (15, 27, 28) , China (4, 10, 12, 36) and other geographical regions (3, 31) ( Table 5 ). Although low frequencies of mutations in codon 516 in clinical isolates have been reported from various parts of China (4, 12, 36), we found a higher frequency of this mutation (15.6%), which was comparable to that of North India (20.5%) (27) .
Phenotypically RIF-resistant isolates with no rpoB mutations in our study were 2.8 %, similar to those reported previously (3, 10, 12, 26, 28) . Therefore, this finding suggested that majority of RIF-resistant isolates in Nepal could be rapidly detected by screening for the most common genetic alterations in RRDR of the rpoB gene, although the prevalence of isolates lacking mutations also needs to be considered.
Previous studies indicated that INH resistance was mediated by mutations in
several genes, most commonly katG, particularly in codon 315, and the promoter region of inhA (6, 11, 16, 24) . Accordingly, we found that 87.6 % and 12.4 % of phenotypically INH-resistant clinical isolates had point mutations in katG and the inhA promoter region, respectively, and the frequencies were similar to those reported by other researchers (1, 3, 8) . However, no deletion or insertion in katG was detected in any isolates in this study. This result confirmed previous reports from different geographic regions of the rarity of this event in causing INH resistance (4, 8, 10, 11, 12, 16, 22) . The seven (6.2%) INH-resistant M. tuberculosis isolates had no resistantassociated alterations in the two targets analyzed, indicating that resistance in these isolates could be due to mutations present outside of the sequenced area or in other genes (e.g. kasA, ndh) (6, 8, 26) .
It has been postulated that the amino acid substitution KatG Ser315Thr is favored by the bacteria because this alteration was elucidated to spoil INH activation and, on the other hand, to retain 30%-40% of the catalase-peroxidase activity necessary for virulence (25) ; however, the prevalence of KatG Ser315Thr substitution in M. tuberculosis isolates around the world varies, especially with regard to the prevalence of TB. In general, a higher prevalence of this substitution has been observed in high TB burden regions, often with the predominance of Beijing and MDR M. tuberculosis strains, compared to regions where the prevalence of TB is intermediate or low (10, 17) .
The present study documented the prevalence of KatG Ser315Thr substitution in 81.4% of INH-resistant isolates, which was not as high as those reported in INH-resistant isolates in north eastern Russia (93.6%) (17) , but was comparable to those in Lithuania and Germany (85.7% and, 88.4%, respectively) (1, 26) . The occurrence of KatG Ser315Thr alteration among Nepalese isolates was higher than that reported in India (16, 22) and China (4, 10, 12) ( Table 6 ).
Van Soolingen et al. (32) reported that strains having amino acid substitutions in KatG315 are more likely to develop resistance to other drugs. In this respect, we found a correlation between this alteration and resistance to other drugs: 100% of isolates with KatG315 substitution showed resistance to RIF. Meanwhile, this mutation was found among 92 in 109 (84.4%) of MDR and none in four non-MDR INH-resistant isolates. This is consistent with the finding of previous studies in which substitutions in codon 315 of KatG are more common in MDR isolates (6, 26, 31) . Several studies from different countries have shown that about 10% to 34% of INH-resistant cases have mutations in the inhA promoter region (11, 34) . In contrast, this study identified mutations in only 12.4 % of INH-resistant isolates, the majority of which was C to T at -15.
As
Nepal shares an open border with north India, there is large population movement between these countries (20). Patients from north India usually come to Nepal because of cheaper TB treatment facilities in Nepal; thus, we postulated the frequent air-born transmission of TB between these points (33) . By comparing data with neighboring countries, we observed a similarity between Nepalese and north Indian RIF-resistant isolates in the occurrence of mutations in codons 531, 526 and 516 of the rpoB gene (Table 5 ). In contrast, the frequency of KatG Ser315Thr substitution and C to T mutations at -15 in inhA promoter between Nepalese and north Indian INH-resistant isolates showed a significant difference (Table 6 ). This discrepancy might not suggest transport but the possible emergence of MDR-TB in Nepal. For confirmation, molecular typing of strains circulating in Nepal and north India seems to be necessary.
In conclusion, this study provides valuable information on mutations occurring at b North India (n=110) and South India (n=39).
c South India (n=35), North India (n=6) and West India (n=3).
d Collected only in Shanghai (n=242).
e South China (n=26), North China (n=16) and East China (n=30). 
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